Adjusted EBITDA increased 7% to $88 million with an adjusted EBITDA margin of 29.5%.
Cash flow from operations was $188 million year-to-date, with free cash flow of $175 million after CapEx of $13 million.
Europe and Rest of World net sales increased 3% to $44 million with gross profit margins increasing 390 basis points sequentially to 38.9%.
Gross profit margins increased to a record 52.7%, representing the 10th consecutive quarter of year-over-year gross margin expansion.
Net leverage was significantly reduced to 2.1x, near the low end of the targeted range of 2 to 3x and the lowest level in over 3 years.
Net sales increased 5% to approximately $300 million, driven by a 5% increase in net price, 2% lower volumes, and a 2% contribution from the ChlorKing acquisition.
North American net sales increased 6% to $255 million with a 220 basis point increase in gross profit margin to 55.1%.